Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 129 | 162 | 200 | 258 | 328 | 435 | 610 | 779 | 910 | 1,042 | | 1,042 |
% Growth | NA | 25.8% | 23.5% | 28.7% | 27.3% | 32.6% | 40.2% | 27.8% | 16.9% | 14.4% | | |
| | | | | | | | | | | | |
Cost of Revenue | (59) | (67) | (83) | (104) | (135) | (180) | (271) | (368) | (433) | (475) | | (475) |
Gross Profit | 69 | 95 | 117 | 154 | 193 | 255 | 338 | 411 | 478 | 566 | | 566 |
% Revenue | 53.8% | 58.7% | 58.5% | 59.6% | 59.0% | 58.5% | 55.5% | 52.8% | 52.5% | 54.4% | | 54.4% |
| | | | | | | | | | | | |
Research and Development | (23) | (24) | (27) | (34) | (45) | (69) | (107) | (142) | (157) | (166) | | (166) |
Selling and Marketing | (42) | (53) | (67) | (72) | (96) | (132) | (194) | (262) | (297) | (308) | | (308) |
General and Admin | (24) | (25) | (27) | (40) | (49) | (66) | (88) | (95) | (116) | (124) | | (124) |
Other Inc / (Exp) | (2) | (1) | (2) | (0) | (0) | (7) | (6) | (0) | (7) | (13) | | (13) |
Total Operating Exp | (91) | (103) | (123) | (147) | (190) | (274) | (395) | (499) | (576) | (611) | | (611) |
| | | | | | | | | | | | |
Operating Income | (21) | (8) | (6) | 7 | 3 | (19) | (56) | (88) | (99) | (45) | | (45) |
% Revenue | -16.4% | -4.7% | -2.9% | 2.7% | 1.0% | -4.4% | -9.2% | -11.2% | -10.8% | -4.3% | | -4.3% |
| | | | | | | | | | | | |
Interest Expense | (5) | (4) | (3) | (7) | (8) | (25) | (8) | (3) | 19 | 32 | | 32 |
Pre-tax Income | (26) | (12) | (9) | 0 | (4) | (45) | (64) | (90) | (79) | (13) | | (13) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (0) | (0) | (0) | (0) | 2 | 11 | (4) | (2) | (0) | | (0) |
Net Income to Company | (26) | (12) | (9) | (0) | (5) | (42) | (53) | (95) | (82) | (13) | | (13) |
% Margin | -20.0% | -7.3% | -4.5% | -0.1% | -1.4% | -9.7% | -8.7% | -12.2% | -9.0% | -1.2% | | -1.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (26) | (12) | (9) | (0) | (5) | (42) | (53) | (95) | (82) | (13) | | (13) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (26) | (12) | (9) | (0) | (5) | (42) | (53) | (95) | (82) | (13) | | (13) |
% Margin | -20.0% | -7.3% | -4.5% | -0.1% | -1.4% | -9.7% | -8.7% | -12.2% | -9.0% | -1.2% | | -1.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.52) | (0.23) | (0.16) | (0.00) | (0.08) | (0.66) | (0.79) | (1.35) | (1.13) | (0.17) | | (0.17) |
Diluted EPS (Continuing Ops) | (0.52) | (0.23) | (0.16) | (0.00) | (0.08) | (0.66) | (0.79) | (1.35) | (1.13) | (0.17) | | (0.17) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 50.14 | 52.34 | 54.95 | 58.08 | 60.37 | 64.15 | 67.51 | 69.92 | 72.05 | 74.50 | | 74.50 |
WA Diluted Shares Out. | 50.14 | 52.34 | 54.95 | 58.08 | 60.37 | 64.15 | 67.51 | 69.92 | 72.05 | 74.50 | | 74.50 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (26) | (12) | (9) | 0 | (4) | (45) | (64) | (90) | (79) | (13) | | (13) |
Addback: Net Interest Expense | 5 | 4 | 3 | 7 | 8 | 25 | 8 | 3 | (19) | (32) | | (32) |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 7 | 8 | 8 | 10 | 14 | 25 | 39 | 45 | 49 | 53 | | 53 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | | 10 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 12 | | 12 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 1 | 0 | 0 | 0 | 7 | 6 | 0 | 0 | (7) | | (7) |
Adjusted EBITDA | (14) | 2 | 4 | 17 | 18 | 13 | (12) | (43) | (43) | 24 | | 24 |
% Margin | -10.7% | 1.1% | 2.2% | 6.7% | 5.5% | 2.9% | -1.9% | -5.5% | -4.8% | 2.3% | | 2.3% |
| | | | | | | | | | | | |
Adjusted EBIT | (21) | (7) | (4) | 7 | 4 | (12) | (51) | (87) | (92) | (29) | | (29) |
% Margin | -16.4% | -4.0% | -1.9% | 2.7% | 1.1% | -2.8% | -8.3% | -11.2% | -10.1% | -2.8% | | -2.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (26) | (12) | (9) | (0) | (5) | (42) | (53) | (95) | (82) | (13) | | (13) |
Addback: Unusual Items | 0 | 1 | 2 | 0 | 0 | 7 | 6 | 0 | 7 | 15 | | 15 |
Less: Tax Benefit of Unusual Items (26%) | 0 | (0) | (0) | 0 | (0) | (2) | (1) | (0) | (2) | (4) | | (4) |
Adjusted Net Income | (26) | (11) | (8) | (0) | (4) | (37) | (49) | (94) | (77) | (1) | | (1) |
% Margin | -20.0% | -6.8% | -3.8% | -0.1% | -1.3% | -8.5% | -8.0% | -12.1% | -8.4% | -0.1% | | -0.1% |